Results 11 to 20 of about 52 (39)
Scientific Opinion on the safety and efficacy of Cylactin® (Enterococcus faecium) as a feed additive for cats and dogs [PDF]
EFSA Journal, 2013 Cylactin® is the trade name for a preparation of Enterococcus faecium. It is currently authorised for use in chickens for fattening, pigs for fattening, piglets, sows, calves, turkeys for fattening, cats and dogs in various formulation.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
doaj +1 more source
Scientific Opinion on Cylactin® (Enterococcus faecium) for calves, lambs and kids for rearing and for fattening [PDF]
EFSA Journal, 2013 Cylactin® consists of dehydrated cells of a strain of Enterococcus faecium. It is authorised for use in feeds for chickens, turkeys and pigs for fattening, piglets, sows, calves and cats and dogs. The applicant is now seeking re-evaluation when used with
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
doaj +1 more source
EFSA Journal, 2014 Cylactin® is a product consisting of viable cells of Enterococcus faecium NCIMB 10415. In a previous opinion, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) assessed a tolerance study conducted with chickens for fattening,
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
doaj +1 more source
Czech Journal of Animal Science, 2017 The effect of glutamine and/or probiotic (Enterococcus feacium) supplements on piglet performance, intestines structure, and microbial status was estimated on 181 piglets (16 litters) of Polish Landrace.
Ewa Hanczakowska +3 more
doaj +1 more source
Scientifica, Volume 2015, Issue 1, 2015., 2015 The aim of this study has been to elucidate the effect of the probiotic Enterococcus faecium NCIMB 10415 on epithelial integrity in intestinal epithelial cells and whether pre‐ and coincubation with this strain can reproducibly prevent damage induced by enterotoxigenic (ETEC) and enteropathogenic Escherichia coli (EPEC).
Ulrike Lodemann +6 more
wiley +1 more source
Mediators of Inflammation, Volume 2015, Issue 1, 2015., 2015 Probiotics have shown positive effects on gastrointestinal diseases; they have barrier‐modulating effects and change the inflammatory response towards pathogens in studies in vitro. The aim of this investigation has been to examine the response of intestinal epithelial cells to Enterococcus faecium NCIMB 10415 (E.
Shanti Klingspor +8 more
wiley +1 more source
The Many Faces of Enterococcus spp.-Commensal, Probiotic and Opportunistic Pathogen. [PDF]
Microorganisms, 2021 Krawczyk B +3 more
europepmc +1 more source
The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales. [PDF]
Antibiotics (Basel), 2021 Hung YP +5 more
europepmc +1 more source
Swine enteric colibacillosis: Current treatment avenues and future directions. [PDF]
Front Vet Sci, 2022 Castro J +6 more
europepmc +1 more source
Ex-Vivo Adhesion of Enterococcus faecalis and Enterococcus faecium to the Intestinal Mucosa of Healthy Beagles. [PDF]
Animals (Basel), 2021 Hanifeh M +5 more
europepmc +1 more source